OncoOne
Biotechnology ResearchWien, Austria11-50 Employees
OncoOne is a biotech start-up dedicated to develop innovative therapeutics to treat patients with solid tumors and inflammation.
Innovative Therapeutics OncoOne is actively developing advanced monoclonal antibodies targeting oxMIF for cancer and inflammation, indicating a strong potential for partnerships in biologic therapeutics and diagnostic tools.
Funding & Growth With $14 million in Series A funding and ongoing research initiatives, OncoOne has resources available to expand its product pipeline, offering opportunities for collaborators in clinical development and commercialization.
Recent Collaborations The company's partnership with GenScript ProBio to develop monoclonal antibodies signals openness to external manufacturing and research collaborations, creating avenues for service providers and technology licensors.
Market Focus Specializing in precision medicines for solid tumors and autoimmune diseases, OncoOne presents opportunities for sales of specialty reagents, diagnostic platforms, and therapeutic delivery solutions tailored to oncology and immunology sectors.
Technology Adoption The company's use of advanced research techniques positions them for engaging with vendors offering cutting-edge biotech tools, analytics services, and digital marketing platforms to support their R&D efforts.
OncoOne uses 8 technology products and services including LiteSpeed Cache, RSS, Font Awesome, and more. Explore OncoOne's tech stack below.
| OncoOne Email Formats | Percentage |
| First.Last@oncoone.com | 50% |
| First.Last@oncoone.com | 50% |
Biotechnology ResearchWien, Austria11-50 Employees
OncoOne is a biotech start-up dedicated to develop innovative therapeutics to treat patients with solid tumors and inflammation.
OncoOne has raised a total of $14M of funding over 1 rounds. Their latest funding round was raised on Mar 18, 2020 in the amount of $14M.
OncoOne's revenue is estimated to be in the range of $1M
OncoOne has raised a total of $14M of funding over 1 rounds. Their latest funding round was raised on Mar 18, 2020 in the amount of $14M.
OncoOne's revenue is estimated to be in the range of $1M